- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10:06 | Niu Technologies to Report First Quarter 2026 Financial Results on May 18, 2026 | ||
| 10:06 | Octopus Apollo VCT plc: Re-Opening of Offer for Subscription to Further Applications | ||
| 09:42 | Jyske Realkredit A/S: Data on debtor composition | ||
| 09:36 | Jyske Realkredit A/S: Preliminary data on early redemptions (prepayments) | ||
| 09:06 | Ringkjøbing Landbobank A/S: Share buyback programme - week 16 | ||
| 08:36 | Jyske Bank: Share repurchase programme: Transactions of week 16 2026 | ||
| 08:36 | Diversified Energy Company: Diversified Energy TR-1 | ||
| 08:06 | ICG Enterprise Trust Plc: Transaction in Own Shares | ||
| 08:06 | OSB GROUP PLC - Transaction in Own Shares | ||
| 08:06 | Bang & Olufsen A/S: Major Shareholder Announcement | ||
| 08:06 | Equinor ASA: Buy-back of shares to share programmes for employees | ||
| 07:36 | TGS ASA: TGS Webcast Details for Q1 2026 Presentation | ||
| 07:12 | AS Infortar: Aktsiaselts Infortar own share acquisition transactions | ||
| 07:06 | AS Infortar: Aktsiaselts Infortar to continue buy-back of up to 250,000 own shares | ||
| 07:06 | A subsidiary of EfTEN Real Estate Fund AS sold an office building at Menulio 11 in Vilnius | ||
| 07:06 | Trifork Group AG: Trifork Announces New Board Members to Advance Product-Led Growth and AI Strategy | ||
| 07:06 | RUBIS: Composition of the Supervisory Board | ||
| 02:06 | ASCENTAGE PHARMA GROUP INTERNATIONAL: Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting | ||
| 01:48 | Sutro Biopharma, Inc.: Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026 | ||
| 01:06 | Monopar Therapeutics Inc.: Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026 | ||
| So | Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons | ||
| So | Revolution Medicines, Inc.: Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting | ||
| Sa | Pliant Therapeutics, Inc.: Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting | ||
| Sa | argenx SE: argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP | ||
| Sa | Grupo Aeroportuario del Pacífico, S.A.B. de C.V.: Grupo Aeroportuario del Pacifico Announces Filing of 2025 Annual Report and Form 20-F |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.